You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

Citation Tools

Article menu

Download PDFPDF

XML
Inflammatory bowel disease
Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Otagiri S, Ohnishi S, Miura A, et al
Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial
BMJ Open Gastroenterology 2018;5:e000206. doi: 10.1136/bmjgast-2018-000206